A Novel Monoclonal Antibody to CD40 Prolongs Islet Allograft Survival

Nondepleting Anti-CD40-Based Therapy Prolongs Allograft Survival in Nonhuman Primates

(2011) I. R. Badell et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Reduction of CD4+ T Cells In Vivo Does Not Affect Virus Load in Macaque Elite Controllers

(2011) P. A. Mudd et al.   JOURNAL OF VIROLOGY

Belatacept-Based Regimens Are Associated With Improved Cardiovascular and Metabolic Risk Factors Compared With Cyclosporine in Kidney Transplant Recipients (BENEFIT and BENEFIT-EXT Studies)

(2011) Yves Vanrenterghem et al.   TRANSPLANTATION

A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

(2010) F. Vincenti et al.   AMERICAN JOURNAL OF TRANSPLANTATION

LFA-1–specific therapy prolongs allograft survival in rhesus macaques

(2010) Idelberto R. Badell et al.   JOURNAL OF CLINICAL INVESTIGATION

Belatacept-Based Regimens Versus a Cyclosporine A-Based Regimen in Kidney Transplant Recipients: 2-Year Results From the BENEFIT and BENEFIT-EXT Studies

(2010) Christian P. Larsen et al.   TRANSPLANTATION

A Human Anti-CD40 Monoclonal Antibody, 4D11, for Kidney Transplantation in Cynomolgus Monkeys: Induction and Maintenance Therapy

(2009) T. Aoyagi et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Posttransplant Diabetes Mellitus and Acute Rejection: Impact on Kidney Transplant Outcome

(2009) Arthur J. Matas et al.   TRANSPLANTATION